The deal price is nearly triple Synthorx's Friday closing price above $25. One of Sanofi's goals is to build its oncology franchise, the CEO said in a statement.

ArQule shares surge after the cancer drug specialists agreed to a $2.7 billion takeover bid from Merck & Co.

Jim Cramer said millennials played a big part in Thor Industries' colossal earnings beat.

Thor Industries beat FactSet's expectations but missed Zacks bottom-line estimates.

Conditions seem ripe for continued upward momentum in stocks, as long as the Federal Reserve or unexpected shocks don't get in the way.

Elon Musk will soon allow Dogecoin to purchase SpaceX merchandise.

The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.

Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.

Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.